Skip to main content
Clinical Trials/NCT05425108
NCT05425108UnknownNot Applicable

Effectiveness of Binocular Peripheral Myopic Projected Defocus on Ocular Biometrics Using a Clinical Prototype Device

Kubota Vision Inc.1 site in 1 country45 target enrollmentStarted: June 23, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
45
Locations
1
Primary Endpoint
Central axial length

Study Overview

Brief Summary

Kubota Vision Inc. has developed a spectacle-like prototype device which is designed to be used as a light-based therapy to reduce myopia progression. In this study, we aim to observe the ocular biometric and refractive changes following binocular part-time wear of the clinical prototype device over a course of 12 months and compare that to 12 months of no clinical prototype device use (control).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
7 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Spherical equivalent -0.50 to -5.50 diopters
  • visual acuity of at least 20/25 in each eye

Exclusion Criteria

  • history of ocular trauma or major eye surgery
  • active ocular infection
  • any prior history or participation in myopia control treatments within the past 3 months

Outcomes

Primary Outcomes

Central axial length

Time Frame: 12 months

Cycloplegic refraction

Time Frame: 12 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kubota Vision Inc.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials